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Introduction
Malignant fibrous histiocytoma (MFH) is a malignant
tumor of fibroblasts and pleomorphic histiocytoid
cells with a large number of bizarre, multinucleated
giant cells [1]. MFH accounts for 20–24% of soft tissue
sarcomas, making it the most common soft tissue
sarcoma occurring in late adult life. MFH occurs most
commonly in the extremities (70–75%, with lower
extremities accounting for 59% of cases), followed by
the retroperitoneum. Tumors typically arise in the deep
fascia or skeletal muscle. MFH has rarely been reported
in the lung, kidney, bladder, heart, stomach, small
intestine, and other soft tissues or organs. It is the
second most common primary cardiac sarcoma with
a frequency of 11.7% [1]. Only 46 cases of primary car-
diac MFH have been reported until now [2]. MFH is
not often associated with pregnancy [3].
We present the case of a postpartum woman who
had antepartal undiagnosed sarcoma with multiple
metastasis. Although she underwent aggressive treat-
ment with surgery and chemotherapy, she died 3 months
after the vaginal delivery of a healthy baby.
Case Report
A 38-year-old mother, gravida 2, para 1, visited our hos-
pital for the first time at 35 weeks of gestation due to
chest tightness. She had normal prenatal care from a
local doctor and did not have any systemic disease or
history of surgery. She complained of intermittent chest
pain and shortness of breath for 1 month. No other
symptoms or signs were noted. The physical examination
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revealed stable vital signs and symmetrical expansion
with clear breathing sounds. Local tenderness on the
left sternal border was noted. We ordered complete
electrocardiography (ECG) and transferred the patient
to the cardiovascular department under the suspicion
of ischemic heart disease. The ECG revealed non-specific
ST-segment and T-wave changes, and the patient was
recommended to come for outpatient follow-up and
echocardiography was scheduled.
After this examination, the patient returned home
and preterm premature rupture of the membrane
(PPROM) was noted early next morning. A female
infant (Apgar score, 9–10; weight, 2,090 g) was born
vaginally 6 hours after PPROM. During the 3 days of
hospitalization, the patient’s vital signs were stable
and intermittent chest pains were also noted, but they
did not become severe. In addition, she complained of
right arm and shoulder pain during hospitalization. We
traced her history and she had felt the pain for 3 months
but because she thought that her shoulder pain was
related to her pregnancy, she did not seek treatment,
and only had massage to relieve her pain. She could not
describe the pattern of the pain but it was vague and
irritating. Physical examination revealed no palpable
mass or any visible lesion on the right arm or shoulder.
No limitation of the range of motion in the right arm
was noted. Therefore, musculofascial pain was diag-
nosed and a nonsteroidal anti-inflammatory drug was
prescribed. Six days after delivery, she came to our
hospital emergency room because her right arm pain
had become more severe. A humeral neck tumor with
bone destruction was found in the right shoulder during
X-ray examination (Figure 1). She was transferred to our
orthopedic department for further evaluation. Frozen
section of the incision biopsy showed pleomorphic
sarcoma. After biopsy, scheduled echocardiography
revealed a left atrial mass, which suggested myxoma.
Transesophageal echocardiography revealed a huge
mass (about 4 × 4 cm) over the left atrium. Chest com-
puted tomography showed a mass of about 4 × 4 × 3
cm in the left atrium of the heart (Figure 2) and a
heterogeneous mass of about 10.8 × 10 cm in the right
lobe of the liver. Cardiac surgeons removed the mass in
the left atrium and the patient recovered well. Ten days
after cardiac surgery, the orthopedic surgeon excised
the right shoulder tumor and reconstructed the shoulder.
Liver biopsy was also performed during this admission.
All the removed specimens were sent for patho-
logic examination, and the results showed a sarcoma
favoring MFH with its primary origin in the left atrium
(Figure 3).
The bone scan showed multiple bony metastasis.
The patient was transferred to the oncology department
Figure 2. Computed tomography with contrast enhancement
of the heart shows a hypodensity mass about 4 × 4 × 3 cm in
the left atrium of the heart (black arrow).
Figure 1. X-ray of right shoulder 6
days after vaginal delivery shows
a humeral neck tumor with bone
destruction (white arrow).
Figure 3. Pathologic specimen (hematoxylin and eosin, × 200)
of a heart sarcoma, composed of markedly pleomorphic,
large, and ovoid to irregularly shaped tumor cells, as well as
spindle tumor cells, favoring malignant fibrous histiocytoma.
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for two courses of adjuvant chemotherapy with liposo-
mal doxorubicin (Lipo-Dox).
Unfortunately, the patient died 3 months after
delivery from MFH with multiple metastasis complicated
by pneumonia and respiratory failure.
Discussion
MFH sometimes originates from the heart, frequently
the left atrium. Because of its location, the symptoms of
cardiac MFH are related to pulmonary congestion due
to pulmonary vein obstruction, mitral stenosis, mitral
regurgitation, and right ventricular failure [1]. Echo-
cardiography is the primary tool for diagnosis of intra-
cardiac mass lesions [4], but a histologic study of the
operative specimen is necessary.
Patients with MFH have had poor outcomes because
of the high propensity for local recurrence and
hematogeneous spread [5]. The most common sites of
metastasis are the lung and bone [5]. In our case, we
first discovered this tumor during an incisional biopsy of
the right humerus.
When this pregnant woman complained about her
right shoulder pain and mild chest discomfort during a
routine prenatal care examination in the last trimester,
we thought the discomfort was possibly related to the
last trimester of pregnancy. That is why it is so difficult
to diagnose this malignancy during prenatal care.
Early radical surgery, even during pregnancy, can
improve survival [6]. The survival of patients with MFH
is determined by the metastatic outcomes. Zagars et
al reported a 5-year survival rate of 68% with this tum-
or [5]. In our case, the low immune response during
pregnancy and the delayed diagnosis were the most
important factors accounting for the metastasis of the
tumor.
After discussion with the physicians in the depart-
ments of hematology and oncology, we decided to
prescribe Lipo-Dox as the chemotherapy regimen. For
more than 20 years, the Soft Tissue and Bone Sarcoma
Group of the European Organization for Research and
Treatment of Cancer has been investigating different
chemotherapy regimens for advanced and metastatic
soft tissue sarcomas. Only a few drugs are active in this
disease. Doxorubicin remains the most active single
agent, with response rates of 20–25%. In an effort to
improve results, many combination regimens have been
investigated as first-line treatment in advanced soft
tissue sarcoma. Despite higher response rates in some
studies, no multidrug regimen has yet been proven
superior to single-agent doxorubicin in terms of overall
survival [7].
Based on the findings of this case report and other
reports described in the literature, we suggest that
obstetricians should be aware of the possible existence
of MFH, and that careful measures should be taken to
avoid tumor spread, maternal morbidity, and even
death.
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